Abstract:
The present invention includes a method of detecting nerve cell damage representative of glaucoma including the steps of: imaging a human retina in vivo, measuring the reflected light intensity at a first predetermined wavelength wherein values returned from healthy and damaged areas of retina are substantially identical, measuring a second reflected light intensity at a predetermined wavelength wherein values of healthy and damaged retina substantially diverge, and recording the differences between the first and second values, which values are indicative of glaucoma damage.